In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.

Dutta, N K; Kumar, K Asok; Mazumdar, Kaushiki; Dastidar, Sujata G.
Indian J Exp Biol ; 2004 Sep; 42(9): 922-7
Artículo en Inglés | IMSEAR | ID: sea-60401

Documentos relacionados

  1. In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.
  2. Mycobacterium abscessus: a new antibiotic nightmare.
  3. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
  4. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease.
  5. Demonstration of plasmid-mediated drug resistance in Mycobacterium abscessus.
  6. Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model.
  7. In vivo evaluation of antibiotic activity against Mycobacterium abscessus.
  8. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.
  9. Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin.
  10. Antibiofilm potential over time of a tricalcium silicate material and its association with sodium diclofenac.